Agile Therapeutics reported 2.13M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Adma Biologics ADMA:US $ 33.9M 4.8M
Agile Therapeutics AGRX:US 2.13M 365K
Bayer BAYN:GR € 12819M 1820M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
JAZZ PHA JAZZ:US $ 932.88M 119.16M
Johnson & Johnson JNJ:US $ 24020M 594M
Merk MRK:US $ 14593M 1308M
Pacira Pharmaceuticals PCRX:US $ 169.41M 11.42M
Pfizer PFE:US $ 27742M 2081M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M
Therapeuticsmd TXMD:US 28.56M 9.23M